Management of dyslipidemia.
Akel
M M
MM
Department of Family Medicine, American University of Beirut-Medical Center, Lebanon. ma00@aub.edu.lb
Salti
I
I
D000328:Adult; D000367:Age Factors; D002648:Child; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000209:etiology; D048909:Diabetes Complications; D015444:Exercise; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000145:classification / Q000150:complications / Q000175:diagnosis / Q000178:diet therapy / Q000628:therapy*; D015228:Hypertriglyceridemia / Q000209:etiology / Q000628:therapy; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D008019:Life Style; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D010349:Patient Compliance; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood
D000960:Hypolipidemic Agents; D008055:Lipids; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D014280:Triglycerides; D002784:Cholesterol